The latest news updates from the 2024 Symposium
-
View from the Trenches: Panel reviews practice-changing presentations from SABCS 2022
Read More: View from the Trenches: Panel reviews practice-changing presentations from SABCS 2022On Friday, December 9, experts highlighted the updates from SABCS 2022 that may have an immediate impact for patients and physicians.
-
Year in Review session summarizes important developments in breast cancer
Read More: Year in Review session summarizes important developments in breast cancerAndrei Goga, MD, PhD; Shom Goel, MBBS; Marleen Kok, MD, PhD; and Melinda Telli, MD, outlined updates across the spectrum of breast cancer research and clinical practice on Saturday, December 10.
-
Panelists examine key clinical controversies in breast cancer
Read More: Panelists examine key clinical controversies in breast cancerViviana Galimberti, MD, and fellow panelists explored evolving questions around the utility of targeted axillary dissection, the optimal duration of endocrine therapy, and the role of neoadjuvant therapy in triple negative breast cancer during a session Wednesday, December 7.
-
Experts debate current controversies in translational medicine
Read More: Experts debate current controversies in translational medicineHope S. Rugo, MD, opened a discussion session on Thursday, December 8, which explored different opinions on the future of minimum tolerable dose (MTD), randomized trials vs. real-world evidence, and the utility of Ki67 as a clinical biomarker.
-
AACR distinguished lecturer delves into prognosis potential of genomic subtypes of breast cancer
Read More: AACR distinguished lecturer delves into prognosis potential of genomic subtypes of breast cancerCharles M. Perou, PhD, spoke Wednesday, December 7, about the importance of quantitative and objective means for measuring the intrinsic subtypes and immune signatures of breast cancer.
-
General Session 4 includes latest results from Alliance, POLAR, POSITIVE studies
Read More: General Session 4 includes latest results from Alliance, POLAR, POSITIVE studiesThe fourth General Session featured data from trials on breast-conserving therapy and local recurrence, short-term recurrence rates in patients who pause endocrine therapy to pursue pregnancy, and more.
-
General Session 5 features novel approaches to CNS metastases
Read More: General Session 5 features novel approaches to CNS metastasesThe fifth General Session included data from two preclinical studies suggesting new approaches to both treating and identifying brain metastases in triple negative and inflammatory breast cancer.
-
AACR Outstanding Investigator awardee discusses breast cancer prevention in younger women
Read More: AACR Outstanding Investigator awardee discusses breast cancer prevention in younger womenAdetunji T. Toriola, MD, PhD, MPH, spoke Friday about his work in identifying molecular determinants of mammographic density and breast cancer risk in premenopausal women.
-
Brinker Award recipient recounts trailblazing work in breast conservation, genomic testing
Read More: Brinker Award recipient recounts trailblazing work in breast conservation, genomic testingNorman Wolmark, MD, FACS, FRCSC, received the Brinker Award for Scientific Distinction in Clinical Research on Friday for his pioneering work in breast conservation, clinical trials, and landmark genomic testing.
-
Don’t miss the Year In Review
Read More: Don’t miss the Year In ReviewThe 2022 Symposium concludes Saturday morning with the always popular Year In Review session led by SABCS Co-directors Virginia Kaklamani, MD, and Carlos Arteaga, MD.